Outset Medical, Inc.
Total Trades
215
Buys
1
Sells
159
Largest Trade
N/A
Insiders
11
Institutional Funds
75
Inst. Value
$1M+
Activist Filings
49
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Nash Marc | EVP Operations R&D… | SELL | $15K–$50K | 6K | $5.10 | Jan 22, 2026 |
| Brottem John L. | General Counsel | SELL | $50K–$100K | 10K | $5.11 | Jan 22, 2026 |
| Trigg Leslie | Chair and CEO | SELL | $50K–$100K | 14K | $5.11 | Jan 21, 2026 |
| Nash Marc | EVP Operations R&D… | SELL | <$1K | 108 | $4.27 | Jan 8, 2026 |
| Brottem John L. | General Counsel | SELL | <$1K | 224 | $4.27 | Jan 8, 2026 |
| Trigg Leslie | Chair and CEO | SELL | $1K–$15K | 2K | $4.27 | Jan 8, 2026 |
| Drexler Karen | Director | SELL | $1K–$15K | 2K | $4.37 | Dec 2, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $1K–$15K | 916 | $4.60 | Nov 18, 2025 |
| Nash Marc | EVP Operations R&D… | SELL | $1K–$15K | 247 | $4.60 | Nov 18, 2025 |
| Brottem John L. | General Counsel | SELL | $1K–$15K | 388 | $4.60 | Nov 18, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $15K–$50K | 935 | $17.80 | May 16, 2025 |
| Nash Marc | SVP Operations and… | SELL | $1K–$15K | 252 | $17.82 | May 16, 2025 |
| Brottem John L. | General Counsel | SELL | $1K–$15K | 396 | $17.82 | May 16, 2025 |
| Ahmed Nabeel | CFO | SELL | $1K–$15K | 584 | $17.81 | May 16, 2025 |
| Trigg Leslie | Chair and CEO | GRANT | N/A | 99K | — | Jan 22, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $50K–$100K | 65K | $0.80 | Jan 22, 2025 |
| Nash Marc | SVP Operations and… | SELL | $15K–$50K | 23K | $0.80 | Jan 22, 2025 |
| Nash Marc | SVP Operations and… | GRANT | N/A | 6K | — | Jan 22, 2025 |
| Brottem John L. | General Counsel | SELL | $15K–$50K | 33K | $0.80 | Jan 22, 2025 |
| Brottem John L. | General Counsel | GRANT | N/A | 9K | — | Jan 22, 2025 |
| Ahmed Nabeel | CFO | SELL | $15K–$50K | 34K | $0.80 | Jan 22, 2025 |
| Ahmed Nabeel | CFO | GRANT | N/A | 13K | — | Jan 22, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $15K–$50K | 33K | $0.81 | Jan 13, 2025 |
| Nash Marc | SVP Operations and… | SELL | $1K–$15K | 15K | $0.81 | Jan 13, 2025 |
| Brottem John L. | General Counsel | SELL | $15K–$50K | 20K | $0.81 | Jan 13, 2025 |
| Ahmed Nabeel | CFO | SELL | $15K–$50K | 29K | $0.81 | Jan 13, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $1K–$15K | 10K | $1.29 | Jan 8, 2025 |
| Nash Marc | SVP Operations and… | SELL | <$1K | 720 | $1.29 | Jan 8, 2025 |
| Brottem John L. | General Counsel | SELL | $1K–$15K | 2K | $1.29 | Jan 8, 2025 |
| Ahmed Nabeel | CFO | SELL | $1K–$15K | 2K | $1.29 | Jan 8, 2025 |
| Trigg Leslie | Chair and CEO | SELL | $1K–$15K | 6K | $0.80 | Nov 18, 2024 |
| Nash Marc | SVP Operations and… | SELL | $1K–$15K | 1K | $0.80 | Nov 18, 2024 |
| Brottem John L. | General Counsel | SELL | $1K–$15K | 3K | $0.80 | Nov 18, 2024 |
| Ahmed Nabeel | CFO | SELL | $1K–$15K | 4K | $0.80 | Nov 18, 2024 |
| Brottem John L. | General Counsel | SELL | $50K–$100K | 11K | $4.78 | Jun 14, 2024 |
| GROSSMAN D KEITH | Director | EXERCISE | $50K–$100K | 69K | $1.11 | Jun 3, 2024 |
| GROSSMAN D KEITH | Director | SELL | $100K–$500K | 38K | $3.78 | Jun 3, 2024 |
| Ahmed Nabeel | CFO | SELL | $1K–$15K | 2K | $3.15 | Mar 4, 2024 |
| Williamson Steven S. | Chief Commercial O… | SELL | $1K–$15K | 3K | $3.57 | Feb 16, 2024 |
| Trigg Leslie | Chair and CEO | SELL | $15K–$50K | 5K | $3.57 | Feb 16, 2024 |
| Racine Jean-Olivier | CTO | SELL | $1K–$15K | 2K | $3.57 | Feb 16, 2024 |
| Nash Marc | SVP Operations and… | SELL | $1K–$15K | 617 | $3.57 | Feb 16, 2024 |
| Brottem John L. | General Counsel | SELL | $1K–$15K | 3K | $3.57 | Feb 16, 2024 |
| Ahmed Nabeel | CFO | SELL | $15K–$50K | 4K | $3.57 | Feb 16, 2024 |
| Williamson Steven S. | Chief Commercial O… | GRANT | N/A | 218K | — | Jan 18, 2024 |
| Williamson Steven S. | Chief Commercial O… | SELL | $1K–$15K | 996 | $4.29 | Jan 18, 2024 |
| Trigg Leslie | Chair and CEO | SELL | $15K–$50K | 8K | $4.29 | Jan 18, 2024 |
| Trigg Leslie | Chair and CEO | GRANT | N/A | 457K | — | Jan 18, 2024 |
| Racine Jean-Olivier | CTO | GRANT | N/A | 201K | — | Jan 18, 2024 |
| Racine Jean-Olivier | CTO | SELL | $1K–$15K | 723 | $4.29 | Jan 18, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 75 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1.6M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 833K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 560K | $1M+ | SH |
| BML Capital Management, LLC | 543K | $1M+ | SH |
| PFM Health Sciences, LP | 531K | $1M+ | SH |
| Assenagon Asset Management S.A. | 508K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 346K | $1M+ | SH |
| STATE STREET CORP | 330K | $1M+ | SH |
| DEUTSCHE BANK AG\ | 164K | $500K+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 149K | $500K+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 127K | $100K–$500K | SH |
| Birchview Capital, LP | 99K | $100K–$500K | SH |
| GMT CAPITAL CORP | 98K | $100K–$500K | SH |
| PURA VIDA INVESTMENTS, LLC | 5K | $100K–$500K | SH |
| STIFEL FINANCIAL CORP | 80K | $100K–$500K | SH |
| MORGAN STANLEY | 78K | $100K–$500K | SH |
| C WorldWide Group Holding A/S | 67K | $100K–$500K | SH |
| MARSHALL WACE, LLP | 64K | $100K–$500K | SH |
| Squarepoint Ops LLC | 59K | $100K–$500K | SH |
| BlackRock, Inc. | 48K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
0.0%
0 shares
SC 13G/A · Feb 13, 2026
10.5%
1.9M shares
SC 13G · Feb 11, 2026
5.2%
951K shares
SC 13G · Jan 14, 2026
9.4%
1.7M shares
SC 13G/A · Nov 14, 2025
7.6%
1.4M shares
T. Rowe Price Investment Management, Inc.
SC 13G/A · Nov 14, 2025
0.0%
2K shares
SC 13G/A · Oct 17, 2025
6.8%
1.2M shares
SC 13G · Jul 29, 2025
5.6%
991K shares
SC 13G · Jul 18, 2025
5.5%
981K shares
SC 13G/A · May 15, 2025
6.7%
1.2M shares
Alyeska Investment Group, L.P.
SC 13G · May 15, 2025
9.6%
1.7M shares
SC 13G · May 15, 2025
7.5%
1.3M shares
T. Rowe Price Investment Management, Inc.
SC 13G/A · May 14, 2025
8.9%
1.6M shares
SC 13G/A · Apr 7, 2025
14.5%
2.6M shares
SC 13G · Mar 17, 2025
9.4%
25.0M shares
SC 13G · Mar 1, 2025
9.5%
5.6M shares
SC 13G/A · Feb 12, 2025
7.0%
3.7M shares
SC 13G/A · Jan 31, 2025
5.0%
2.6M shares
SC 13G · Jan 10, 2025
9.9%
26.6M shares
SC 13G/A · Nov 12, 2024
5.1%
2.6M shares
SC 13G/A · Nov 12, 2024
3.6%
1.9M shares
SC 13G/A · Nov 12, 2024
9.2%
4.8M shares
SC 13G/A · Nov 4, 2024
5.1%
2.6M shares
Ameriprise Financial, Inc. IRS No. 13-3180631
SC 13G/A · Sep 10, 2024
3.4%
1.8M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Sep 9, 2024
1.4%
708K shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Sep 5, 2024
0.2%
135K shares
SC 13G · Aug 23, 2024
5.5%
2.8M shares
SC 13G/A · Jul 8, 2024
1.7%
880K shares
Ameriprise Financial, Inc. IRS No. 13-3180631
SC 13G/A · Apr 10, 2024
10.1%
5.1M shares
Ameriprise Financial, Inc. IRS No. 13-3180631
SC 13G · Feb 14, 2024
5.9%
3.0M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Feb 14, 2024
6.3%
3.2M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
7.8%
3.9M shares
SC 13G/A · Feb 13, 2024
3.5%
1.8M shares
SC 13G/A · Jan 26, 2024
7.6%
3.8M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 23, 2024
9.4%
4.7M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Sep 8, 2023
10.0%
5.0M shares
SC 13G · Feb 14, 2023
5.9%
2.8M shares
SC 13G/A · Feb 14, 2023
0.0%
6 shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Feb 14, 2023
7.3%
3.5M shares
AllianceBernstein L.P. 13-4064930
SC 13G/A · Feb 14, 2023
0.1%
56K shares
SC 13G/A · Jan 31, 2023
7.2%
3.5M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jan 25, 2023
9.3%
4.5M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Jul 7, 2022
10.8%
5.2M shares
SC 13G/A · Feb 14, 2022
4.0%
1.9M shares
AllianceBernstein L.P. 13-4064930
SC 13G · Feb 14, 2022
5.6%
2.6M shares
SC 13G/A · Feb 14, 2022
6.2%
6 shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Jan 26, 2022
6.1%
2.9M shares